Logo
csv. check, some, votes

Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole

Reference: B9-0103/2019

Date: 10.10.2019

← Previous
Next →
Member country
Overall Result
Total: 751 MEPs
402 For
222 Against
39 Abstention
88 No vote
402 For
222 Against
39 Abstention
88 No vote
Martina ANDERSON
Foto von Martina ANDERSON
Col pr, CC BY-SA 4.0, via Wikimedia Commons

Country: United Kingdom

Group: The Left in the European Parliament – GUE/NGL

Plenary contributions: 0

My vote:
For
European People's Party (EPP)
For: 27
Against: 130
Abstention: 2
No vote: 23
Click for details
Progressive Alliance of Socialists and Democrats (S&D)
For: 137
Against: 0
Abstention: 3
No vote: 14
Click for details
Renew Europe (Renew)
For: 56
Against: 34
Abstention: 7
No vote: 11
Click for details
Greens/European Free Alliance (Greens/EFA)
For: 68
Against: 0
Abstention: 0
No vote: 6
Click for details
Identity and Democracy (ID)
For: 50
Against: 13
Abstention: 0
No vote: 10
Click for details
European Conservatives and Reformists (ECR)
For: 4
Against: 43
Abstention: 2
No vote: 13
Click for details
Non-attached Members (NI)
For: 21
Against: 2
Abstention: 25
No vote: 9
Click for details
The Left in the European Parliament (GUE/NGL)
For: 39
Against: 0
Abstention: 0
No vote: 2
Click for details
← Back to home